Home / IL-33 / Human IL-33 DuoSet ELISA

Human IL-33 DuoSet ELISA

Catalog #: DY3625B
36 Citations 5 Reviews Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
DY3625B-05
DY3625B
Ancillary Products Available
DY008B: DuoSet ELISA Ancillary Reagent Kit 2
DY999B: Substrate Reagent Pack
DY999: Substrate Reagent Pack
Human Fucose Detection ELISA Standard Curve
2 Images
Product Details
Procedure
Citations (36)
FAQs
Supplemental Products
Reviews (5)
Summary Product Features Kit Content Other Reagents Required Data Examples Product Datasheets Preparation and Storage Background

Human IL-33 DuoSet ELISA Summary

Assay Type
Solid Phase Sandwich ELISA
Format
96-well strip plate
Assay Range
23.4 - 1,500 pg/mL
Sufficient Materials
For fifteen 96-well plates*
Specificity
Please see the product datasheet

* Provided that the recommended microplates, buffers, diluents, substrates and solutions are used, and the assay is run as summarized in the Assay Procedure provided.

This DuoSet ELISA Development kit contains the basic components required for the development of sandwich ELISAs to measure natural and recombinant human Interleukin 33 (IL-33). The suggested diluent is suitable for the analysis of most cell culture supernate, serum, and plasma samples. Diluents for complex matrices, such as serum and plasma, should be evaluated prior to use in this DuoSet.

Product Features

  • Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
  • Development protocols are provided to guide further assay optimization
  • Assay can be customized to your specific needs
  • Economical alternative to complete kits

Kit Content

  • Capture Antibody
  • Detection Antibody
  • Recombinant Standard
  • Streptavidin conjugated to horseradish-peroxidase (Streptavidin-HRP)

Other Reagents Required

DuoSet Ancillary Reagent Kit 2 (5 plates): (Catalog # DY008) containing 96 well microplates, plate sealers, substrate solution, stop solution, plate coating buffer (PBS), wash buffer, and Reagent Diluent Concentrate 2.

The components listed above may be purchased separately:

PBS: (Catalog # DY006), or 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2 - 7.4, 0.2 µm filtered

Wash Buffer: (Catalog # WA126), or 0.05% Tween® 20 in PBS, pH 7.2-7.4

Block Buffer: (Catalog # DY995), or 1% BSA in PBS, pH 7.2-7.4, 0.2 µm filtered

Reagent Diluent: 0.1% BSA, 0.05% Tween 20 in Tris-buffered Saline (20 mM Trizma base, 150 mM NaCI) pH 7.2-7.4, 0.2 μm filtered

Substrate Solution: 1:1 mixture of Color Reagent A (H2O2) and Color Reagent B (Tetramethylbenzidine) (Catalog # DY999)

Stop Solution: 2 N H2SO4 (Catalog # DY994)

Microplates: R&D Systems (Catalog # DY990)

Plate Sealers: ELISA Plate Sealers (Catalog # DY992)

Scientific Data

N/A Human Fucose Detection ELISA Standard Curve View Larger

Human Fucose Detection ELISA Standard Curve

N/A View Larger

Human IL-33 ELISA Standard Curve

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Preparation and Storage

Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: IL-33

IL-33 (Interleukin-33) is released from physically damaged or necrotic cells. It triggers Th2-biased immune cell activation at sites of inflammation as well as regulatory T cell and M2 macrophage expansion. It additionally induces angiogenesis, promotes tumor cell migration and invasion, limits cardiac myocyte hypertrophy, and limits the development of atherosclerotic plaques. IL-33 signals through a receptor complex composed of ST2 and IL-1 RAcP. IL-1 RAcP also associates with IL-1 RI, IL-1 RII, IL-1 R6, and SCF R/c-kit. Soluble isoforms of ST2 and IL-1 RAcP function as decoy receptors that regulate IL-33 bioactivity.

Long Name:
Interleukin 33
Entrez Gene IDs:
90865 (Human); 77125 (Mouse)
Alternate Names:
C9orf26; C9orf26chromosome 9 open reading frame 26 (NF-HEV); DKFZp586H0523; DVS27; DVS27-related protein; IL1F11; IL-1F11; IL33; IL-33; interleukin 33; Interleukin-1 family member 11; interleukin-33; NFHEV; NF-HEV; NF-HEVNFEHEV; Nuclear factor from high endothelial venules; RP11-575C20.2

Assay Procedure

GENERAL ELISA PROTOCOL

Plate Preparation

  1. Dilute the Capture Antibody to the working concentration in PBS without carrier protein. Immediately coat a 96-well microplate with 100 μL per well of the diluted Capture Antibody. Seal the plate and incubate overnight at room temperature.
  2. Aspirate each well and wash with Wash Buffer, repeating the process two times for a total of three washes. Wash by filling each well with Wash Buffer (400 μL) using a squirt bottle, manifold dispenser, or autowasher. Complete removal of liquid at each step is essential for good performance. After the last wash, remove any remaining Wash Buffer by aspirating or by inverting the plate and blotting it against clean paper towels.
  3. Block plates by adding 300 μL of Block Buffer to each well. Incubate at room temperature for a minimum of 1 hour.
  4. Repeat the aspiration/wash as in step 2. The plates are now ready for sample addition.

Assay Procedure

  1. Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at room temperature.
  2. Repeat the aspiration/wash as in step 2 of Plate Preparation.
  3. Add 100 μL of the Detection Antibody, diluted in Reagent Diluent, to each well. Cover with a new adhesive strip and incubate 2 hours at room temperature.
  4. Repeat the aspiration/wash as in step 2 of Plate Preparation.
  5. Add 100 μL of the working dilution of Streptavidin-HRP to each well. Cover the plate and incubate for 20 minutes at room temperature. Avoid placing the plate in direct light.
  6. Repeat the aspiration/wash as in step 2.
  7. Add 100 μL of Substrate Solution to each well. Incubate for 20 minutes at room temperature. Avoid placing the plate in direct light.
  8. Add 50 μL of Stop Solution to each well. Gently tap the plate to ensure thorough mixing.
  9. Determine the optical density of each well immediately, using a microplate reader set to 450 nm. If wavelength correction is available, set to 540 nm or 570 nm. If wavelength correction is not available, subtract readings at 540 nm or 570 nm from the readings at 450 nm. This subtraction will correct for optical imperfections in the plate. Readings made directly at 450 nm without correction may be higher and less accurate.

Citations for Human IL-33 DuoSet ELISA

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

36 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis
    Authors: Jiao, M;Wang, C;Tang, X;Dai, C;Zhang, N;Fan, A;Qian, Z;Liu, S;Zhang, F;Li, B;Xu, Y;Tan, Z;Gong, F;Lu, Y;Zheng, F;
    Brain, behavior, and immunity
    Species: Mouse, Transgenic Mouse
    Sample Types: Cell Culture Supernates
  2. Activator protein transcription factors coordinate human IL-33 expression from noncanonical promoters in chronic airway disease
    Authors: Raphael, HE;Hassan, GF;Osorio, OA;Cohen, LS;Payne, MD;Katz-Kiriakos, E;Tata, I;Hicks, J;Byers, DE;Zhang, B;Alexander-Brett, J;
    JCI insight
    Species: Human
    Sample Types: Cell Culture Supernates, Cell Lysates
  3. Serum TGF-?1 and CD14 Predicts Response to Anti-TNF-? Therapy in IBD
    Authors: Coufal, S;Kverka, M;Kreisinger, J;Thon, T;Rob, F;Kolar, M;Reiss, Z;Schierova, D;Kostovcikova, K;Roubalova, R;Bajer, L;Jackova, Z;Mihula, M;Drastich, P;Tresnak Hercogova, J;Novakova, M;Vasatko, M;Lukas, M;Tlaskalova-Hogenova, H;Jiraskova Zakostelska, Z;
    Journal of immunology research
    Species: Human
    Sample Types: Serum
  4. Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
    Authors: England, E;Rees, DG;Scott, IC;Carmen, S;Chan, DTY;Chaillan Huntington, CE;Houslay, KF;Erngren, T;Penney, M;Majithiya, JB;Rapley, L;Sims, DA;Hollins, C;Hinchy, EC;Strain, MD;Kemp, BP;Corkill, DJ;May, RD;Vousden, KA;Butler, RJ;Mustelin, T;Vaughan, TJ;Lowe, DC;Colley, C;Cohen, ES;
    Scientific reports
    Species: Human
    Sample Types: Cell Culture Supernates
  5. Symbiotic microbiome Staphylococcus epidermidis restricts IL-33 production in allergic nasal epithelium via limiting the cellular necroptosis
    Authors: Jeon, YJ;Gil, CH;Won, J;Jo, A;Kim, HJ;
    BMC microbiology
    Species: Mouse
    Sample Types: Nasal Lavage Fluid
  6. Adiponectin and Interleukin-33: Possible Early Markers of Metabolic Syndrome
    Authors: J Nesic, B Ljujic, V Rosic, A Djukic, M Rosic, I Petrovic, N Zornic, IP Jovanovic, S Petrovic, S Djukic
    Journal of Clinical Medicine, 2022-12-24;12(1):.
    Species: Human
    Sample Types: Plasma
  7. Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease-A 10-Year Cohort Study
    Authors: MH Urban, S Stojkovic, S Demyanets, C Hengstenbe, A Valipour, J Wojta, OC Burghuber
    Journal of Clinical Medicine, 2021-12-23;11(1):.
    Species: Human
    Sample Types: Serum
  8. COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males
    Authors: W Fonseca, N Asai, K Yagi, CA Malinczak, G Savickas, CC Johnson, S Murray, EM Zoratti, NW Lukacs, J Li, CF Schuler Iv
    Viruses, 2021-12-02;13(12):.
    Species: Human
    Sample Types: Whole Blood
  9. Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia
    Authors: ICS Dias, SM de Campos-, ELM Vieira, APL Mota, PS Azevedo, VTDS Anício, FC Guimarães, LM Mantovani, BF Cruz, AL Teixeira, JV Salgado
    Journal of psychiatric research, 2021-11-09;0(0):.
    Species: Human
    Sample Types: Serum
  10. Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study
    Authors: R Rezar, V Paar, C Seelmaier, I Pretsch, P Schwaiger, K Kopp, R Kaufmann, TK Felder, E Prinz, G Gemes, R Pistulli, UC Hoppe, B Wernly, M Lichtenaue
    Scientific Reports, 2021-11-05;11(1):21756.
    Species: Human
    Sample Types: Serum
  11. PGC-1&alpha regulates airway epithelial barrier dysfunction induced by house dust mite
    Authors: T Saito, T Ichikawa, T Numakura, M Yamada, A Koarai, N Fujino, K Murakami, S Yamanaka, Y Sasaki, Y Kyogoku, K Itakura, H Sano, K Takita, R Tanaka, T Tamada, M Ichinose, H Sugiura
    Respiratory Research, 2021-02-19;22(1):63.
    Species: Human
    Sample Types: Cell Culture Supernates
  12. Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection
    Authors: T Li, Z Zhang, JG Bartolacci, GK Dwyer, Q Liu, L Mathews, M Velayutham, A Roessing, YC Lee, H Dai, S Shiva, MH Oberbarnsc, JL Dziki, SJ Mullett, SG Wendell, JD Wilkinson, SA Webber, MA Wood-Trage, SC Watkins, AJ Demetris, GS Hussey, SF Badylak, HR Turnquist
    J. Clin. Invest., 2020-10-01;0(0):.
    Species: Human
    Sample Types: Serum
  13. Gene expression network analyses during infection with virulent and avirulent Trypanosoma cruzi�strains unveil a role for fibroblasts in neutrophil recruitment and activation
    Authors: AER Oliveira, MCA Pereira, AT Belew, LRP Ferreira, LMN Pereira, EGA Neves, MDCP Nunes, BA Burleigh, WO Dutra, NM El-Sayed, RT Gazzinelli, SMR Teixeira
    PLoS Pathog., 2020-08-18;16(8):e1008781.
    Species: Human
    Sample Types: Cell Culture Supernates
  14. The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
    Authors: S Demyanets, C Kaun, A Kaider, W Speidl, M Prager, S Oravec, P Hohensinne, J Wojta, G Rega-Kaun
    Cardiovasc Diabetol, 2020-02-26;19(1):26.
    Species: Human
    Sample Types: Serum
  15. Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis
    Authors: D Izadi, TB Layton, L Williams, F McCann, M Cabrita, AI Espirito S, W Xie, M Fritzsche, H Colin-York, M Feldmann, KS Midwood, J Nanchahal
    Sci Adv, 2019-12-04;5(12):eaay0370.
    Species: Human
    Sample Types: Cell Culture Supernates
  16. Helicobacter pylori Induces IL-33 Production and Recruits ST-2 to Lipid Rafts to Exacerbate Inflammation
    Authors: CJ Kuo, CY Chen, HR Lo, CL Feng, HY Wu, MZ Huang, TN Liao, YA Chen, CH Lai
    Cells, 2019-10-21;8(10):.
    Species: Human
    Sample Types: Cell Fraction
  17. Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation
    Authors: N Schaunaman, A Sanchez, KG Dimasuay, N Pavelka, M Numata, R Alam, RJ Martin, HW Chu
    Infect. Immun., 2019-06-20;87(7):.
    Species: Human
    Sample Types: Cell Culture Supernates
  18. Substance P and IL-33 administered together stimulate a marked secretion of IL-1? from human mast cells, inhibited by methoxyluteolin
    Authors: A Taracanova, I Tsilioni, P Conti, ER Norwitz, SE Leeman, TC Theoharide
    Proc. Natl. Acad. Sci. U.S.A., 2018-09-19;0(0):.
    Species: Human
    Sample Types: Serum
  19. The Effects of Varying Degree of MWCNT Carboxylation on Bioactivity in Various In Vivo and In Vitro Exposure Models
    Authors: RF Hamilton, Z Wu, S Mitra, A Holian
    Int J Mol Sci, 2018-01-25;19(2):.
    Species: Human
    Sample Types: Cell Culture Supernates
  20. Double-stranded RNA released from damaged articular chondrocytes promotes cartilage degeneration via Toll-like receptor 3-interleukin-33 pathway
    Authors: C Li, K Chen, H Kang, Y Yan, K Liu, C Guo, J Qi, K Yang, F Wang, L Guo, C He, L Deng
    Cell Death Dis, 2017-11-02;8(11):e3165.
    Species: Human
    Sample Types: Tissue Homogenates
  21. Predictive value of low interleukin-33 in critically ill patients
    Authors: KA Krychtiuk, S Stojkovic, M Lenz, M Brekalo, K Huber, J Wojta, G Heinz, S Demyanets, WS Speidl
    Cytokine, 2017-09-30;0(0):.
    Species: Human
    Sample Types: Serum
  22. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population
    Authors: GA Queiroz, RS Costa, NM Alcantara-, G Nunes de O, ML Barreto, VL Carneiro, CA Figueiredo
    Int. J. Immunogenet, 2017-04-01;44(2):51-61.
    Species: Human
    Sample Types: Cell Culture Supernates
  23. IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma
    Authors: I Hentschke, A Graser, VO Melichar, A Kiefer, T Zimmermann, B Kro beta, P Haag, P Xepapadaki, NG Papadopoul, C Bogdan, S Finotto
    Sci Rep, 2017-03-06;7(0):43426.
    Species: Human
    Sample Types: Tissue Secretion
  24. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis
    Authors: Gisa Tiegs
    J. Immunol., 2016-11-21;0(0):.
    Species: Human
    Sample Types: Plasma
  25. Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33.
    Authors: Calven J, Akbarshahi H, Menzel M, Ayata C, Idzko M, Bjermer L, Uller L
    J Transl Med, 2015-08-29;13(0):281.
    Species: Human
    Sample Types: Cell Culture Supernates
  26. Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences.
    Authors: Sundnes O, Pietka W, Loos T, Sponheim J, Rankin A, Pflanz S, Bertelsen V, Sitek J, Hol J, Haraldsen G, Khnykin D
    J Invest Dermatol, 2015-03-04;135(7):1771-80.
    Species: Human
    Sample Types: Cell Lysates
  27. IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects.
    Authors: Hasan, Amal, Al-Ghimlas, Fahad, Warsame, Samia, Al-Hubail, Asma, Ahmad, Rasheed, Bennakhi, Abdullah, Al-Arouj, Monira, Behbehani, Kazem, Dehbi, Mohammed, Dermime, Said
    BMC Immunol, 2014-05-10;15(0):19.
    Species: Human
    Sample Types: Serum
  28. Serum soluble ST2 is associated with ER-positive breast cancer.
    Authors: Lu, Da-Peng, Zhou, Xiang-Yu, Yao, Lu-Tian, Liu, Cai-Gang, Ma, Wei, Jin, Feng, Wu, Yun-Fei
    BMC Cancer, 2014-03-18;14(0):198.
    Species: Human
    Sample Types: Serum
  29. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.
    Authors: Guerrero C, Arrieta A, Ramirez N, Rodriguez L, Vega R, Bosch I, Rodriguez J, Narvaez C, Salgado D
    Cytokine, 2013-01-26;61(3):766-71.
    Species: Human
    Sample Types: Plasma
  30. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33.
    J. Exp. Med., 2012-07-16;209(8):1505-17.
    Species: Human
    Sample Types: Cell Culture Supernates
  31. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.
    Authors: Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T
    Clin. Exp. Allergy, 2012-02-01;42(2):218-28.
    Species: Human
    Sample Types: Serum
  32. ST2 and IL-33 in pregnancy and pre-eclampsia.
    Authors: Granne I, Southcombe JH, Snider JV
    PLoS ONE, 2011-09-16;6(9):e24463.
    Species: Human
    Sample Types: Cell Culture Supernates
  33. Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders.
    Authors: Rechardt M, Shiri R, Matikainen S, Viikari-Juntura E, Karppinen J, Alenius H
    Cytokine, 2011-03-02;54(2):149-53.
    Species: Human
    Sample Types: Serum
  34. High Levels of Soluble ST2 and Low Levels of IL-33 in Sera of Patients with HIV Infection.
    Authors: Miyagaki T, Sugaya M
    J. Invest. Dermatol., 2010-12-09;131(0):794.
    Species: Human
    Sample Types: Serum
  35. Primary sources and immunological prerequisites for sST2 secretion in humans.
    Authors: Mildner M, Storka A, Lichtenauer M
    Cardiovasc. Res., 2010-04-02;87(4):769-77.
    Species: Human
    Sample Types: Cell Culture Supernates
  36. Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts.
    Authors: Nishida A, Andoh A, Imaeda H, Inatomi O, Shiomi H, Fujiyama Y
    Gut, 2009-12-08;59(4):531-41.
    Species: Human
    Sample Types: Cell Culture Supernates

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs
Loading...

Reviews for Human IL-33 DuoSet ELISA

Average Rating: 4.8 (Based on 5 Reviews)

5 Star
80%
4 Star
20%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human IL-33 DuoSet ELISA?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human IL-33 DuoSet ELISA
By Anonymous on 12/14/2020
Sample Tested: Cell culture supernatant
Human IL-33 DuoSet ELISA DY3625B
Human IL-33 DuoSet ELISA
By Anonymous on 04/02/2020
Sample Tested: Serum and Plasma

We used this kit for the quantification of CD27 in human serum and plasma. Works ok and well-described protocol.

Human IL-33 DuoSet ELISA DY3625B
Human IL-33 DuoSet ELISA
By Anonymous on 09/16/2019
Sample Tested: Cell culture supernatant
Human IL-33 DuoSet ELISA
By Anonymous on 08/22/2019
Sample Tested: EDTA Plasma
Human IL-33 DuoSet ELISA
By Anonymous on 08/11/2017
Sample Tested: Human serum
Human IL-33 DuoSet ELISA DY3625B